Search NaijaAgroNet

Wednesday, January 20, 2021

Genetic diversity: 3 funding mechanism to explore - NaijaAgroNet: ... Linking agrobiz, sustainable environs, people & technology

NaijaAgroNet:

The Project Africa GRADIENT comprises three funding mechanisms to support, including fellowships, investigator-sponsored research and seed-fund, reports 
NaijaAgroNet.
For the fellowships: A limited number of fellowships in academic institutions with a reputation for global excellence to collect and analyse data on determinants of drug response.



The Investigator-sponsored research: Hypothesis-driven research focused on understanding genetic regional variation in drug response.

While the Seed-Fund: A limited number of projects to enable the exploration of new research goals, depending on the results from 1 and 2.

NaijaAgroNet reports that within the scope of the agreement, the South African Medical Research Council (SAMRC) will administer the project, and a Joint Steering Committee will oversee the review of submitted proposals.

Also, 
NaijaAgroNet gathered that priority will be given to research aimed at collecting data from currently under-represented regions and improving the scientific robustness of inconsistent data. All datasets collated are planned to be released in a public database to catalyse a positive change in approach to understanding variations in treatment efficacy and safety for patients across the continent.

Prof. Glenda Gray, SAMRC President and CEO, said: “It is exciting to see more and more global partners taking interest in the challenges of Africa. We are delighted that partners are now seeking to address the challenges of Africa by their quest to understand the fundamental differences between genetics of Africa and the rest of the world.”

As a first step, researchers based at universities, science councils and other public research organizations across Africa are invited to express their ‘intent to submit’ through the SAMRC website. Final award recipients are expected to be announced by end of 2021.

Isaac Oyimah/Editor

No comments:

Post a Comment

Share ur views here